Renee Selman - Net Worth and Insider Trading
Renee Selman Net Worth
The estimated net worth of Renee Selman is at least $45 dollars as of 2025-04-30. Renee Selman is the Chief Commercial Officer of Agile Therapeutics Inc and owns about 30 shares of Agile Therapeutics Inc (AGRX) stock worth over $45. Details can be seen in Renee Selman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Renee Selman has not made any transactions after 2017-08-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Renee Selman
Renee Selman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Renee Selman owns 1 companies in total, including Agile Therapeutics Inc (AGRX) .
Click here to see the complete history of Renee Selman’s form 4 insider trades.
Insider Ownership Summary of Renee Selman
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| AGRX | Agile Therapeutics Inc | 2017-08-25 | Chief Commercial Officer |
Renee Selman Latest Holdings Summary
Renee Selman currently owns a total of 1 stock. Renee Selman owns 30 shares of Agile Therapeutics Inc (AGRX) as of August 25, 2017, with a value of $45.
Latest Holdings of Renee Selman
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGRX | Agile Therapeutics Inc | 2017-08-25 | 30 | 1.51 | 45 |
Holding Weightings of Renee Selman
Renee Selman Form 4 Trading Tracker
According to the SEC Form 4 filings, Renee Selman has made a total of 0 transactions in Agile Therapeutics Inc (AGRX) over the past 5 years. The most-recent trade in Agile Therapeutics Inc is the acquisition of 4 shares on August 25, 2017, which cost Renee Selman around $24,288.
Insider Trading History of Renee Selman
- 1
Renee Selman Trading Performance
GuruFocus tracks the stock performance after each of Renee Selman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Renee Selman is 24.78%. GuruFocus also compares Renee Selman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Renee Selman within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Renee Selman's insider trading performs compared to the benchmark.
Performance of Renee Selman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.51 | | | | | |
| Relative Return to S&P 500(%) | 11.64 | | | | | |
Renee Selman Ownership Network
Ownership Network List of Renee Selman
Ownership Network Relation of Renee Selman
Renee Selman Owned Company Details
What does Agile Therapeutics Inc do?
Who are the key executives at Agile Therapeutics Inc?
Renee Selman is the Chief Commercial Officer of Agile Therapeutics Inc. Other key executives at Agile Therapeutics Inc include Chief Financial Officer Scott M Coiante , Chief Commercial Officer Amy Welsh , and director & Chief Executive Officer Alfred Altomari .
Agile Therapeutics Inc (AGRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Agile Therapeutics Inc (AGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Agile Therapeutics Inc (AGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Agile Therapeutics Inc (AGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Agile Therapeutics Inc Insider Transactions
Renee Selman Mailing Address
Above is the net worth, insider trading, and ownership report for Renee Selman. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Renee Selman's mailing address is: Philadelphia Pa 19107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
